Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a revenue-generating…
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index…
by admin